Welcome to our dedicated page for AVIENT SEC filings (Ticker: AVNT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on AVIENT's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into AVIENT's regulatory disclosures and financial reporting.
Avient Corporation (AVNT) Form 4 filing: Director Patricia Verduin disclosed the acquisition of 1,187 shares of Avient common stock on 06/30/2025. The transaction is coded “A” (acquired) with a stated price of $0, suggesting a grant or similar non-cash transaction. Following this filing, Verduin now directly owns 23,866 shares of AVNT. No sales or derivative security transactions were reported, and there were no indications of 10b5-1 plan usage. The Form was signed on 07/02/2025 by attorney-in-fact Robert K. James.